Published in Arch Dermatol Res on January 01, 1983
Cefuroxime axetil for treatment of uncomplicated gonorrhea. Antimicrob Agents Chemother (1986) 1.14
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J Infect Dis (1973) 12.22
Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92
Development of a defined minimal medium for the growth of Neisseria gonorrhoeae. Appl Microbiol (1974) 5.18
Glutamine as a Growth Factor for Certain Strains of Neisseria Gonorrhoeae. J Bacteriol (1943) 5.16
Neisseria gonorrhoeae auxotyping: differentiation of clinical isolates based on growth responses on chemically defined media. Appl Microbiol (1973) 4.88
Serology of Neisseria gonorrhoeae. Classification by co-agglutination. Acta Pathol Microbiol Scand B (1980) 2.38
Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science (1977) 2.37
Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae. J Clin Microbiol (1977) 2.22
Phenotypic and epidemiologic correlates of auxotype in Neisseria gonorrhoeae. J Infect Dis (1978) 2.02
Cocarboxylase as a growth factor for certain strains of Neisseria gonorrhoeae. Arch Biochem (1946) 0.80
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42
[On demonstration of E. coli O 91 in dyspepsia]. Zentralbl Bakteriol Orig (1966) 2.20
Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol (1999) 1.96
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
[Antibiotic effects of mixtures of polymethlmethacrylate with antibiotics]. Arch Orthop Unfallchir (1970) 1.68
Effects of pentachlorophenol and some of its known and possible metabolites on fungi. Appl Environ Microbiol (1986) 1.58
The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol (2006) 1.55
Garin-Bujadoux-Bannwarth syndrome. Lancet (1990) 1.43
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids. Eur J Clin Microbiol (1984) 1.42
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
Legionella infection of the colon presenting as acute attack of ulcerative colitis. Gastroenterology (1989) 1.40
[Pyoderma]. Hautarzt (1998) 1.37
Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med (1987) 1.31
Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns. Eur J Clin Microbiol Infect Dis (1996) 1.29
Influence of serum protein binding on the in vitro activity of anti-fungal agents. Infection (1996) 1.23
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol (2004) 1.19
Late cutaneous schistosomiasis representing an isolated skin manifestation of schistosoma mansoni infection. Dermatology (2000) 1.19
[Normal pH value of human skin]. Hautarzt (1986) 1.16
Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med (1997) 1.16
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol (1994) 1.16
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun (1993) 1.14
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study. Antimicrob Agents Chemother (1991) 1.13
Reinfection with Borrelia burgdorferi. Lancet (1986) 1.10
[Isolation of penicillinase forming gonococci in Munich]. MMW Munch Med Wochenschr (1978) 1.07
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol (1995) 1.07
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol (2000) 1.07
Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J Clin Microbiol (1998) 1.06
Microbiological findings in erythema (chronicum) migrans and related disorders. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 1.05
Membrane proteins of legionellaceae. I. Membrane proteins of different strains and serogroups of Legionella pneumophila. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.05
Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05
Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J Cutan Pathol (1993) 1.05
Indirect immunofluorescence assay (IFA), microagglutination test (MA) and enzyme-linked-immunosorbent assay (ELISA) in diagnosis of legionellosis. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.03
A four-year review of fatal Aspergillosis. Eur J Clin Microbiol Infect Dis (1999) 1.03
Species specific membrane proteins of Legionellaceae. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.03
Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6. Genitourin Med (1988) 1.02
The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg (1997) 1.02
Myositis caused by Borrelia burgdorferi: report of four cases. J Neurol Sci (1989) 1.01
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis (1996) 1.01
Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy (1990) 1.01
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol (2001) 0.99
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. Hautarzt (1989) 0.99
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. J Am Acad Dermatol (1990) 0.98
The role of vitamin E in normal and damaged skin. J Mol Med (Berl) (1995) 0.97
Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate. Antimicrob Agents Chemother (1997) 0.97
The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med (Berl) (1996) 0.96
Cross immunity among types of Borrelia burgdorferi. Lancet (1993) 0.96
Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests. Chemotherapy (1998) 0.96
Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab (1990) 0.95
Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study. J Antimicrob Chemother (1983) 0.95
Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model. Infect Immun (1991) 0.95
Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhage. Endoscopy (1984) 0.95
Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci (2007) 0.95
Sensitivity of Neisseria gonorrhoeae to penicillin in West Germany. Br J Vener Dis (1979) 0.95
Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro (2005) 0.95
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. Int J Antimicrob Agents (2001) 0.95
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
Onychomycosis. Mycoses (2007) 0.94
The KEX2 gene of Candida glabrata is required for cell surface integrity. Mol Microbiol (2001) 0.94
Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis (1997) 0.94
Methicillin-resistant Staphylococcus haemolyticus on the hands of health care workers: a route of transmission or a source? J Hosp Infect (1995) 0.93
Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics. Eur J Clin Microbiol (1984) 0.93
Aquarium dermatitis: cercarial dermatitis in an aquarist. Dermatology (1998) 0.93
Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects. Skin Pharmacol Physiol (2004) 0.92
Plasmid content and protein I serovar of non-penicillinase-producing gonococci isolated in Munich. Epidemiol Infect (1988) 0.92
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol (1999) 0.91
No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol (1995) 0.91
Effects of pentachloronitrobenzene and some of its known and possible metabolites on fungi. Appl Environ Microbiol (1983) 0.91
Significance of non-pneumophila Legionella species in adult community-acquired and nosocomial pneumonias. Klin Wochenschr (1987) 0.91
The use of systemic antimycotics in dermatotherapy. Eur J Dermatol (2000) 0.91
Preputial abscesses caused by beta-lactamase-producing gonococci. Cutis (1985) 0.90
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release (2005) 0.90
Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy (1985) 0.90
Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol Suppl (1993) 0.89
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol (2006) 0.89
Reinfection in erythema migrans disease. Infection (1986) 0.89
Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst (1994) 0.89
[The correlation between biotype and antifungal sensitivity of Candida albicans]. Mykosen (1987) 0.89
Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. Acta Derm Venereol (1987) 0.88
Phospholipases of Candida albicans. Mycoses (2001) 0.88
Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.88
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie (2005) 0.88
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich. Genitourin Med (1988) 0.87
Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses (1999) 0.87
Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target (2002) 0.87
Discrimination between clinical and environmental strains of Legionella pneumophila by a monoclonal antibody. Isr J Med Sci (1986) 0.87
HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses (1999) 0.87
Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. Eur J Clin Pharmacol (1985) 0.87
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G. Chemotherapy (1984) 0.86
A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection (1990) 0.86
Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci (1988) 0.86
Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease. J Clin Microbiol (1995) 0.86
Detection of mycobacterial DNA in paraffin-embedded specimens of lupus vulgaris by polymerase-chain reaction. Arch Dermatol Res (1993) 0.86
Management of onychomycoses. Drugs (1999) 0.86
Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assay. J Clin Microbiol (2001) 0.86